Career & Filing History
Every role Jonathan D. Root has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Jonathan D. Root is Director at Edgewise Therapeutics, Inc. (EWTX). SEC records also connect Root to Omada Health, Inc. (OMDA) and CARLSMED, INC. (CARL). Root has reported 13 insider filings with the SEC since 2025. The most recent filing was in July 2026.
Every role Jonathan D. Root has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Edgewise Therapeutics, Inc. (EWTX)1 filingOmada Health, Inc. (OMDA)2 filingsCARLSMED, INC. (CARL)1 filingUpdated Aug 31, 2026
Jonathan D. Root is Director of Edgewise Therapeutics, Inc. (EWTX). 12 SEC Form 4 filings on record going back to 2025, most recently on 17 July 2026. Most recent open-market trade: bought $7.00M of CARL on 25 July 2025. Lifetime open-market purchases: $7.00M.
Every recent SEC Form 4 transaction Jonathan D. Root has reported, most recent first.
InsiderAlpha's records for Jonathan D. Root go back to 2025: 12 primary Form 4 filings, an average of 6.0 per year. The typical open-market purchase is $7.00M (1 buy totaling $7.00M). The largest single buy on record is $7.00M of CARL in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Jonathan D. Root files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Jonathan D. Root is a corporate insider, tracked as Director of Edgewise Therapeutics, Inc. (EWTX). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
4 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 1 open-market purchase ($7.00M) and 0 open-market sales across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$OMDA Omada Health, Inc.10.9K shares @ $0.00-